Business Description
Incyte Corp
NAICS : 541714
SIC : 8731
ISIN : BRI1NCBDR004
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 40.47 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.09 | |||||
Interest Coverage | 20.22 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 5.5 | |||||
Beneish M-Score | -2.29 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.2 | |||||
3-Year Book Growth Rate | 24.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | 57.93 | |||||
Future 3-5Y Total Revenue Growth Rate | 11.04 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.99 | |||||
14-Day RSI | 99.79 | |||||
6-1 Month Momentum % | 26.14 | |||||
12-1 Month Momentum % | 27.77 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.92 | |||||
Quick Ratio | 1.84 | |||||
Cash Ratio | 1.14 | |||||
Days Inventory | 87.45 | |||||
Days Sales Outstanding | 66.69 | |||||
Days Payable | 195.66 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.7 | |||||
Shareholder Yield % | 15.99 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 93.07 | |||||
Operating Margin % | 1.32 | |||||
Net Margin % | 2.52 | |||||
FCF Margin % | -4.96 | |||||
ROE % | 2.09 | |||||
ROA % | 1.56 | |||||
ROIC % | 0.54 | |||||
ROC (Joel Greenblatt) % | 46.01 | |||||
ROCE % | 7.08 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 181 | |||||
Forward PE Ratio | 44.75 | |||||
PE Ratio without NRI | 66.49 | |||||
Shiller PE Ratio | 79.38 | |||||
PS Ratio | 3.79 | |||||
PB Ratio | 4.16 | |||||
Price-to-Tangible-Book | 4.58 | |||||
EV-to-EBIT | 31.29 | |||||
EV-to-Forward-EBIT | 33.14 | |||||
EV-to-EBITDA | 25.1 | |||||
EV-to-Forward-EBITDA | 26.41 | |||||
EV-to-Revenue | 2.87 | |||||
EV-to-Forward-Revenue | 2.66 | |||||
EV-to-FCF | -79.33 | |||||
Price-to-Projected-FCF | 2.19 | |||||
Price-to-Median-PS-Value | 0.43 | |||||
Price-to-Graham-Number | 3.68 | |||||
Price-to-Net-Current-Asset-Value | 13.84 | |||||
Earnings Yield (Greenblatt) % | 3.19 | |||||
FCF Yield % | -1.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Incyte Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil R$) | 19,512.398 | ||
EPS (TTM) (R$) | 0.43 | ||
Beta | 0 | ||
Volatility % | 29.39 | ||
14-Day RSI | 99.79 | ||
14-Day ATR (R$) | 0.37661 | ||
20-Day SMA (R$) | 192.62 | ||
12-1 Month Momentum % | 27.77 | ||
52-Week Range (R$) | 135.9 - 192.82 | ||
Shares Outstanding (Mil) | 385.2 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Incyte Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Incyte Corp Stock Events
Event | Date | Price(R$) | ||
---|---|---|---|---|
No Event Data |
Incyte Corp Frequently Asked Questions
What is Incyte Corp(BSP:I1NC34)'s stock price today?
When is next earnings date of Incyte Corp(BSP:I1NC34)?
Does Incyte Corp(BSP:I1NC34) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |